Anna Sussman | IR |
Patrick Mahaffy | CEO |
Thomas Harding | Chief Scientific Officer |
Lindsey Rolfe | Chief Medical Officer |
Dan Muehl | CFO |
Gavin Scott | JPMorgan |
Tazeen Ahmad | Bank of America |
Paul Choi | Goldman Sachs |
Andrew Berens | SVB Leerink |
Joe Catanzaro | Piper Sandler |
Ladies and gentlemen, thank you for standing by, and welcome to the Clovis Oncology Q2 2021 Operating Results Webcast Conference call. [Operator Instructions] Please be advised that today's conference is being recorded. [Operator Instructions] I would now like to hand the conference over to your speaker, Anna Sussman, Vice President of Investor Relations. Thank you. Please go ahead.